Olink Holding AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- -
- Employees
- 707
- Market Cap
- $3.2B
- Introduction
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions.
Thermo Fisher Launching New CDMO, CRO Services at CPHI Milan
Thermo Fisher Scientific launches Accelerator Drug Development at CPHI Milan 2024, offering customizable services for small molecule, biologics, and cell and gene therapies. The initiative aims to support customers throughout the drug development lifecycle, following recent expansions and acquisitions.
© Copyright 2025. All Rights Reserved by MedPath